Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MORF4L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MORF4L2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMEM31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB9B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB40A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LL0XNC01-116E7.2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMSB15B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BEX3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BEX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BEX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on